SUCAMPO PHARMACEUTICALS INC's ticker is SCMP and the CUSIP is 864909106. A total of 135 filers reported holding SUCAMPO PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $3,105,000 | +47.4% | 172,980 | -3.1% | 1.02% | +46.0% |
| Q3 2017 | $2,107,000 | +257.7% | 178,570 | +218.3% | 0.70% | +315.5% |
| Q2 2017 | $589,000 | -18.9% | 56,107 | -14.9% | 0.17% | -2.9% |
| Q1 2017 | $726,000 | -18.8% | 65,959 | 0.0% | 0.17% | -15.2% |
| Q4 2016 | $894,000 | +8.0% | 65,959 | -1.9% | 0.20% | +4.1% |
| Q3 2016 | $828,000 | +22.7% | 67,269 | +9.4% | 0.20% | +12.0% |
| Q2 2016 | $675,000 | +94.0% | 61,499 | +93.0% | 0.18% | +57.7% |
| Q1 2016 | $348,000 | -34.5% | 31,870 | +3.8% | 0.11% | -34.3% |
| Q4 2015 | $531,000 | -18.4% | 30,700 | -6.3% | 0.17% | -20.3% |
| Q3 2015 | $651,000 | +21.0% | 32,760 | 0.0% | 0.21% | +30.9% |
| Q2 2015 | $538,000 | +5.5% | 32,760 | 0.0% | 0.16% | +4.5% |
| Q1 2015 | $510,000 | – | 32,760 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 1,304,376 | $23,414,000 | 7.30% |
| Kassirer Asset Management Corp | 291,784 | $5,238,000 | 5.39% |
| First Trust Capital Management L.P. | 637,578 | $11,445,000 | 2.19% |
| NEXTHERA CAPITAL LP | 510,486 | $9,163,000 | 1.69% |
| HAVENS ADVISORS LLC | 100,000 | $1,795,000 | 1.35% |
| Piermont Capital Management Inc. | 172,980 | $3,105,000 | 1.02% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 674,446 | $12,106,000 | 0.97% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 1,495,600 | $26,845,000 | 0.96% |
| LONGFELLOW INVESTMENT MANAGEMENT CO LLC | 200,000 | $3,590,000 | 0.87% |
| BOOTHBAY FUND MANAGEMENT, LLC | 332,075 | $5,961,000 | 0.87% |